Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Alopecia areata patients should have eye check-ups due to increased risk of eye problems.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Alopecia Areata causes hair loss and needs treatments that address both physical and emotional health.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Combined oral minoxidil and finasteride significantly improve hair density in men with male pattern baldness.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

No significant genetic link to alopecia areata was found in the Jordanian group.

Diabetic patients need tailored cosmetic treatments for skin aging, with new therapies showing promise.

Atopic dermatitis and alopecia areata have a major global socioeconomic impact, needing more research and better healthcare alignment.

COVID-19 may worsen Parkinson's disease by affecting certain brain proteins.

Combining platelet-rich plasma and minoxidil can effectively regrow hair in severe alopecia areata cases.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

Hair loss in alopecia areata can negatively affect sexual quality of life.

Androgenetic alopecia causes significant psychological distress, especially in women, and requires both medical and psychological support.

Improved diagnosis and affordable topical treatments are essential for managing alopecia areata in India.

Alopecia areata causes significant emotional and social challenges, especially with more hair loss.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Baricitinib may effectively treat nail changes in alopecia areata.

88% phenol is effective for treating alopecia areata.

Effervescent cleansing tablets with Asiatic acid were successfully developed, showing good stability and cleansing effectiveness.

Experts recommend starting systemic treatment for alopecia areata when the condition is severe or causes significant distress.

Alopecia areata affects about 1.93% of people worldwide, with more women affected than men.

Plum-blossom needling with conventional treatments improves hair regrowth in alopecia areata.

Topical corticosteroids are recommended first for treating pediatric alopecia areata due to their safety and ease of use.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.